APA (7th ed.) Citation

D, F., T, K., MI, P., AP, L., I, D., EE, P., . . . S, A. (2025). Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status. Frontiers in oncology, 15, 1606933. https://doi.org/10.3389/fonc.2025.1606933

Chicago Style (17th ed.) Citation

D, Førde, et al. "Prognostic Impact of MiR-17-5p and MiR-20a-5p in NSCLC Diverge in Subgroups According to Lymph Node Status." Frontiers in Oncology 15 (2025): 1606933. https://doi.org/10.3389/fonc.2025.1606933.

MLA (9th ed.) Citation

D, Førde, et al. "Prognostic Impact of MiR-17-5p and MiR-20a-5p in NSCLC Diverge in Subgroups According to Lymph Node Status." Frontiers in Oncology, vol. 15, 2025, p. 1606933, https://doi.org/10.3389/fonc.2025.1606933.